Pneumatic torniquets

Reading File
Pneumatic tourniquets are devices that use compressed gas (air or nitrogen) to apply controlled circumferential pressure to a limb, occluding blood flow for surgical procedures. They consist of a cuff, a pressure regulator, a pressure source, and a display/alarm system.
Searching sources...
Finding Sources
Finding Sources
Searching PubMed

pneumatic tourniquet complications orthopedic surgery

Good hits in Campbell's Operative Orthopaedics 2026 and Pye's. Let me read the key sections now.
Reading File
Reading File
Searching Images

pneumatic tourniquet surgical limb orthopedic

A clinical procedural photograph demonstrating the measurement of a surgical field on a human upper limb. The arm is positioned on a sterile light-blue surgical drape. At the proximal end, a Sterile Standard Tourniquet (SST) is applied over cream-colored protective padding. The pneumatic tourniquet features a black constricting band, black securing straps, a yellow fabric component, and a visible label marked '24 in. (61cm) CE'. A white rigid medical ruler is placed vertically along the posterior aspect of the arm to measure the distance from the distal edge of the sterile tourniquet to the tip of the olecranon (elbow). The ruler shows measurements in both centimeters and inches, indicating a usable surgical field length of approximately 20 cm. This image illustrates perioperative protocols for determining available sterile surgical space when using sterile pneumatic tourniquet systems in orthopedic surgery.

A clinical procedural photograph demonstrating the measurement of a surgical field on a human upper limb. The arm is positioned on a sterile light-blue surgical drape. At the proximal end, a Sterile Standard Tourniquet (SST) is applied over cream-colored protective padding. The pneumatic tourniquet features a black constricting band, black securing straps, a yellow fabric component, and a visible label marked '24 in. (61cm) CE'. A white rigid medical ruler is placed vertically along the posterior aspect of the arm to measure the distance from the distal edge of the sterile tourniquet to the tip of the olecranon (elbow). The ruler shows measurements in both centimeters and inches, indicating a usable surgical field length of approximately 20 cm. This image illustrates perioperative protocols for determining available sterile surgical space when using sterile pneumatic tourniquet systems in orthopedic surgery.

This clinical photograph displays a sterile standard pneumatic (SST) tourniquet cuff designed for surgical use. The device is a black, disposable synthetic fabric cuff featuring a centralized white label. The label identifies the product as a 'Tourniquet Dispo Cuff, Single Cuff' with a specified length of 76 cm (30 inches), and includes manufacturer details for VBM Medizintechnik GmbH. Regulatory and safety symbols are present on the label, including the 'STERILE EO' mark indicating ethylene oxide sterilization, a 'CE 0123' conformity mark, and a 'do not reuse' (single-use) icon. Integral to the pneumatic system, two blue inflation tubes extend from the base of the cuff, terminating in white and gray luer-lock style connectors for attachment to a pressure regulator. A dark blue fabric fastening strap is attached to the lateral side for securing the cuff around a patient's limb. This equipment is primarily used in orthopedic surgery to create a bloodless operative field by occluding distal blood flow.

This clinical photograph displays a sterile standard pneumatic (SST) tourniquet cuff designed for surgical use. The device is a black, disposable synthetic fabric cuff featuring a centralized white label. The label identifies the product as a 'Tourniquet Dispo Cuff, Single Cuff' with a specified length of 76 cm (30 inches), and includes manufacturer details for VBM Medizintechnik GmbH. Regulatory and safety symbols are present on the label, including the 'STERILE EO' mark indicating ethylene oxide sterilization, a 'CE 0123' conformity mark, and a 'do not reuse' (single-use) icon. Integral to the pneumatic system, two blue inflation tubes extend from the base of the cuff, terminating in white and gray luer-lock style connectors for attachment to a pressure regulator. A dark blue fabric fastening strap is attached to the lateral side for securing the cuff around a patient's limb. This equipment is primarily used in orthopedic surgery to create a bloodless operative field by occluding distal blood flow.

A four-panel clinical photograph comparison demonstrating surgical site exposure provided by different tourniquet types in pediatric orthopedic surgery. Panel (a) illustrates a sterile silicone ring tourniquet applied to the upper thigh, showing its narrow profile (approximately 2-3 cm) and excellent proximal limb exposure for a planned femur incision. Panel (b) shows a conventional pneumatic tourniquet on the proximal thigh, which is significantly wider (8-16 cm) and limits surgical access to the upper thigh. Panel (c) demonstrates a sterile silicone ring tourniquet applied to the upper arm for the excision of a distal humerus region lesion (pilomatricoma), showing minimal interference with the operative field. Panel (d) shows the intraoperative application of the silicone ring tourniquet on the proximal thigh during an open reduction and internal fixation of a femur shaft fracture, highlighting its ability to maintain a bloodless field and provide maximal exposure for extensive longitudinal incisions. The images emphasize the educational objective of choosing appropriate hemostatic devices to optimize the surgical field in pediatric patients with short limb lengths.

A four-panel clinical photograph comparison demonstrating surgical site exposure provided by different tourniquet types in pediatric orthopedic surgery. Panel (a) illustrates a sterile silicone ring tourniquet applied to the upper thigh, showing its narrow profile (approximately 2-3 cm) and excellent proximal limb exposure for a planned femur incision. Panel (b) shows a conventional pneumatic tourniquet on the proximal thigh, which is significantly wider (8-16 cm) and limits surgical access to the upper thigh. Panel (c) demonstrates a sterile silicone ring tourniquet applied to the upper arm for the excision of a distal humerus region lesion (pilomatricoma), showing minimal interference with the operative field. Panel (d) shows the intraoperative application of the silicone ring tourniquet on the proximal thigh during an open reduction and internal fixation of a femur shaft fracture, highlighting its ability to maintain a bloodless field and provide maximal exposure for extensive longitudinal incisions. The images emphasize the educational objective of choosing appropriate hemostatic devices to optimize the surgical field in pediatric patients with short limb lengths.

Reading File
Reading File
Reading File
Reading File
Reading File
Loading Image
I now have comprehensive information. Let me compile the full answer.

Pneumatic Tourniquets

A pneumatic tourniquet is a device that uses compressed gas (typically air or nitrogen) to apply controlled, measurable circumferential pressure to a limb, creating a bloodless operative field. It is the preferred tourniquet type in modern orthopaedic and hand surgery because pressure can be precisely monitored and regulated, unlike elastic or rubber bandage tourniquets.

Components and Equipment

A pneumatic tourniquet system consists of:
  • Cuff - an inner inflatable bladder fully enclosed in an outer casing (to prevent "blowout" and pressure loss)
  • Pressure source - compressed gas cylinder or wall supply
  • Pressure gauge/regulator - aneroid or digital; must be calibrated frequently (discrepancy >20 mm Hg requires repair/replacement; gauges have been found to be up to 300 mm Hg off calibration)
  • Alarm system - modern automatic units self-test on startup
Single-use sterile disposable tourniquets are preferred over reusable ones, as reusable cuffs require thorough decontamination to prevent microbial colonization.
Sterile pneumatic tourniquet cuff (VBM Medizintechnik), single-use with dual inflation tubes and luer-lock connectors

Application Technique

  1. Padding: Apply at least two layers of orthopaedic wool/felt (e.g., Webril) smoothly around the limb. Wrinkles must be avoided - they can cause blisters, skin pinching, and necrosis.
  2. Application site: Upper arm (near axilla) for the upper limb; mid/upper thigh for the lower limb. A well-padded proximal calf tourniquet is safe for foot and ankle surgery.
  3. Exsanguination: Elevate the limb for 2-5 minutes, or wrap with a 10 cm elastic bandage from the fingertips proximally just distal to the tourniquet.
  4. Inflation: Inflate to the appropriate pressure (see below).
  5. Skin preparation precaution: Apply a circumferential adhesive-backed plastic drape just distal to the tourniquet to prevent prep solutions from running underneath - otherwise chemical burns can result.
  • Campbell's Operative Orthopaedics 15th Ed 2026

Cuff Selection

  • Wide cuffs are more effective at lower inflation pressures than narrow ones
  • Curved (contoured) cuffs fit conical extremities better and require significantly lower arterial occlusion pressures than straight (rectangular) cuffs
  • Straight tourniquets on conical thighs should be avoided, especially in muscular or obese individuals (risk of skin slough at the upper margin, particularly in the gluteal fold region)
  • Recommended widths: 10 cm for the arm; 15 cm or wider for the leg
Straight vs. curved tourniquet cuff fitting on cylindrical vs. conical limbs

Pressure Guidelines

ExtremityPressure
Upper extremity50-100 mm Hg above systolic, or 135-255 mm Hg
Lower extremityDouble systolic, or 175-305 mm Hg; leg 250-350 mm Hg
Foot/ankle (calf cuff)201-250 mm Hg most commonly used
Thigh cuff (foot/ankle surgery)251-351 mm Hg most commonly used
The limb occlusion pressure (LOP) concept is increasingly preferred: inflate to just above the LOP + a safety margin (50-75 mm Hg), rather than using arbitrary preset pressures. This minimizes tissue injury.

Duration and Timing

  • General maximum: 2 hours (absolute maximum 3 hours; recovery takes 5-7 days)
  • Tourniquet >90 minutes is a risk factor for wound healing complications in elective foot and ankle surgery
  • For longer procedures (anticipated >2.5 hours): employ a 10-minute deflation interval every hour, then consider reducing pressure to 50-75 mm Hg above LOP
Tourniquet duration decision algorithm from Campbell's 2026

Contraindications and Cautions

  • Compromised limb vascularity (peripheral vascular disease, questionable blood supply to the foot)
  • Severe infections (may spread organisms proximally)
  • Sickle cell disease (sickling risk under ischemia)
  • DVT (risk of embolization)
  • Severe hypertension (difficult to achieve adequate occlusion)
  • Use with caution in diabetic neuropathy, severe atherosclerosis, and in patients on anticoagulants

Complications

Because pressure is monitored and controlled, pneumatic tourniquets carry fewer complications than elastic tourniquets - but complications can still occur, driven by a combination of biochemical, biomechanical, microvascular, and cellular mechanisms (Pedowitz et al.):
ComplicationNotes
Tourniquet paralysis (nerve injury)Commonest serious complication; due to direct compression + ischemia; usually neurapraxia, recovers in days-weeks
Muscle injuryIschemia beneath and distal to the cuff; worse with higher pressures and longer duration
Post-tourniquet syndromeEdema, stiffness, pallor, weakness, and heaviness after deflation
Tourniquet painAching pain even under regional anesthesia; requires supplemental sedation or GA for long cases
Chemical burnsFrom skin prep running under the cuff
Skin blistering/necrosisFrom wrinkles in padding or straight cuff on conical limb
DVT/PEVenous stasis during ischemia; hypercoagulable state post-deflation
Cardiac effectsRelease of tourniquet causes sudden drop in SVR and bolus of acidic, hypoxic, hyperkalemic blood - can cause hypotension
Compartment syndromeRare; from reperfusion injury
  • Campbell's Operative Orthopaedics 15th Ed 2026

Forearm Tourniquet (Alternative to Upper Arm)

Several studies have shown forearm tourniquets are safe and reliable for hand procedures:
  • Allows the local anesthetic dose to be reduced to almost half that required with an upper arm tourniquet
  • Lower frequency and severity of tourniquet pain (especially for procedures <25 minutes, or distal to the wrist with regional block)
  • Associated with longer sensory block and prolonged postoperative analgesia

Ten Rules of Pneumatic Tourniquet Use (Braithwaite & Klenerman's Modification of Bruner's Rules)

RuleRecommendation
ApplicationOnly to a healthy limb; with caution to an unhealthy limb
Cuff sizeArm: 10 cm; Leg: 15 cm (or wider for large legs)
SiteUpper arm; mid/upper thigh ideally
PaddingAt least two layers of orthopaedic felt
Pressure50-100 mm Hg above systolic (arm); double systolic (thigh); or arm 200-250 mmHg, leg 250-350 mmHg
DurationGenerally ≤2 hours; absolute max 3 hours
TemperatureAvoid heating (e.g., surgical lights); cool and keep moist when feasible
DocumentationRecord duration and pressure; calibrate weekly; equipment maintenance every 3 months
  • Campbell's Operative Orthopaedics 15th Ed 2026, Table 2.6

Advantage Over Esmarch Tourniquet

A pneumatic tourniquet is safer than the Esmarch (rubber bandage) tourniquet or Martin rubber sheet because pressure is precisely controlled and measurable. The Esmarch's only remaining advantage is that it can sometimes be applied higher on the thigh than a pneumatic cuff.
Key principle: The greatest danger in tourniquet use is an improperly calibrated gauge - gauges have been found to be 300 mm Hg off calibration in documented tourniquet injuries. Routine calibration is non-negotiable.

From millers for Anaesthesia

Searching sources...
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Good. The main anesthesia-relevant sections are in block25 (orthopaedic surgery chapter) and block27 (IVRA). Let me read these in detail.
Reading File
Reading File
Reading File
Reading File
Reading File
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
I now have all the key content from Miller's Anesthesia 10e. Here is the full answer:

Pneumatic Tourniquets - Miller's Anesthesia 10e (2-Volume Set)


Purpose and Basic Settings

A pneumatic tourniquet is routinely used in orthopaedic limb surgery to:
  • Reduce intraoperative blood loss
  • Provide a bloodless field (e.g., for cement fixation in TKA)
Standard inflation pressure: 50-100 mm Hg above the patient's systolic blood pressure Maximum duration: 3 hours
  • Miller's Anesthesia 10e, Hip and Knee Arthroplasties

Haemodynamic Effects

On Inflation

  • Blood from the exsanguinated limb is "autotransfused" centrally - raises preload transiently
  • MAP and SVR may rise

On Deflation (clinically important)

  • Mean arterial blood pressure drops significantly after tourniquet release
  • Two mechanisms:
    1. Release of metabolites from the ischemic limb into systemic circulation
    2. Decrease in peripheral vascular resistance as the limb reperfuses
  • In prolonged cases, the ischemic limb accumulates lactate, CO2, K⁺, and acid - release causes a sudden metabolic acidaemia
  • In replantation surgery, lactic acidosis from prolonged tourniquet time is particularly problematic in patients with underlying lung disease; controlled ventilation is advisable to compensate for metabolic acidosis
  • Miller's Anesthesia 10e, Hip and Knee Arthroplasties; Extremity Replantation

Tourniquet Pain

One of the most clinically relevant anaesthetic considerations:
  • Tourniquet pain typically begins after 60 minutes of inflation
  • It occurs even in the presence of a regional anaesthetic that is adequate for the surgery
  • Mechanism: caused by unblocking of unmyelinated C-fibres during recession of a neuraxial block (C-fibres are more resistant to local anaesthetic block than A-delta fibres and persist longer)
  • Management:
    • Addition of opioids to spinal or epidural anaesthesia may ameliorate tourniquet pain
    • Blocking T2 dermatome helps decrease tourniquet pain in shoulder/elbow surgery (where the tourniquet sits on the upper arm)
    • Dual-cuff technique (for IVRA/Bier block): a second tourniquet is placed distal to the first; inflated 15 minutes after the proximal cuff, then the proximal cuff is deflated - the distal cuff now sits over anaesthetised skin, reducing tourniquet pain
  • Miller's Anesthesia 10e, Hip and Knee Arthroplasties; Hand Surgery; Shoulder and Elbow Surgery

Nerve Injury from Tourniquet

Nerve injury after tourniquet inflation is attributed to the combined effects of ischemia and mechanical trauma.
  • When prolonged tourniquet inflations are required, deflating the tourniquet for 30 minutes of reperfusion may reduce neural ischemia before re-inflation

Post-Deflation Bleeding

After tourniquet release in TKA:
  • Bleeding begins immediately on deflation and can continue for the next 24 hours
  • This must be factored into fluid and transfusion management

Intravenous Regional Anaesthesia (Bier Block) - Tourniquet Protocol

A key technique where tourniquet management is central to safety:
  1. Exsanguinate the arm with an elastic bandage (Esmarch)
  2. Inflate the upper arm tourniquet to 50-100 mm Hg above systolic (often to 250 mm Hg)
  3. Inject preservative-free local anaesthetic (lidocaine; prilocaine preferred in UK/Europe for its high therapeutic index) into a hand vein
  4. Onset: approximately 6-8 minutes
  5. Apply second (distal) cuff 15 minutes later, inflate it, then deflate the proximal cuff - reduces tourniquet pain by positioning the active cuff over anaesthetised skin
  6. Do not deflate before 30 minutes - risk of LAST (systemic local anaesthetic toxicity) from bulk drug release into circulation
  7. Adjuvants (ketorolac, clonidine, dexamethasone, dexmedetomidine) can reduce tourniquet pain and improve block quality, though routine use of ketorolac is now controversial
Key safety point: Complications occur when the tourniquet fails during initial injection or if deflated too early (<30 minutes), both of which risk LAST.
  • Miller's Anesthesia 10e, Hand Surgery; Intravenous Regional Anaesthesia

Contraindication - Specific Patient Populations

ConditionTourniquet Consideration
Ehlers-Danlos Syndrome (EDS)Pneumatic tourniquet avoided unless absolutely necessary (friable skin, vascular fragility, bleeding risk)
Sickle cell / haemoglobinopathiesTourniquet placement worsens hypoxemia risk; regional anaesthesia (especially neuraxial) preferred to reduce sickling
Preexisting sciatic neuropraxia, neuropathic pain, or vascular disease in the operative legOperation can be performed without a tourniquet
Replantation (prolonged tourniquet >90-120 min)Reperfusion intervals should be considered; controlled ventilation to buffer metabolic acidosis
  • Miller's Anesthesia 10e

Foot and Ankle Surgery

  • Thigh or leg tourniquets commonly used to limit blood loss
  • Regional anaesthesia combining sciatic + femoral nerve blocks is sufficient for all procedures below the knee that do not require a thigh tourniquet
  • If a thigh tourniquet is needed, the femoral nerve territory must also be blocked

Summary - Key Anaesthetic Points

IssueMiller's Recommendation
Inflation pressureSystolic BP + 50-100 mm Hg
Max duration3 hours
Tourniquet painBegins ~60 min; C-fibres responsible; add opioids to neuraxial block
On deflationDrop in MAP; release of ischemic metabolites
Nerve injuryIschemia + mechanical compression; reperfuse 30 min if prolonged
IVRA safetyNever deflate <30 min; dual-cuff technique reduces pain
ReplantationControlled ventilation if prolonged tourniquet (lactic acidosis risk)
  • Miller's Anesthesia, 2-Volume Set, 10th Edition (2023)

Possible questions about blood for md Anaesthesia osce exam

Asking for Preferences

Which blood topics should I focus on? · What format do you want?

Searching sources...
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
Reading File
I now have comprehensive content from Miller's. Let me compile the full structured OSCE notes.

Blood - MD Anaesthesia OSCE: Structured Notes with Likely Questions

Source: Miller's Anesthesia, 2-Volume Set, 10th Edition

TOPIC 1: Blood Products - Components and Indications

❓ Likely OSCE Questions

  • "What are the components of a unit of PRBC and how do they differ from whole blood?"
  • "What solutions can and cannot be co-administered with PRBCs? Why?"
  • "What are the indications for FFP, cryoprecipitate, and platelets?"

Key Facts

Packed Red Blood Cells (PRBCs)
  • Haematocrit: ~57-60% (plasma removed)
  • pH: 6.79 | pCO2: 79 mmHg | K⁺: 20.5 mmol/L | Lactate: 9.4 mmol/L
  • Same Hb content as whole blood, with less plasma
  • Suitable for most indications except severe haemorrhage (where whole blood preferred)
Compatible diluents for PRBCs:
  • 0.9% saline, 5% dextrose/0.9% saline, 5% dextrose/0.45% saline, Normosol-R (pH 7.4)
  • Lactated Ringer's CONTRAINDICATED - contains Ca²⁺ which reverses citrate anticoagulation and may cause clotting
  • Hypotonic solutions cause RBC swelling and haemolysis - avoid
Blood Products Summary Table:
ProductContentShelf lifeTempTrigger/Indication
PRBCsRBCs, minimal plasma42 days1-6°CHb <7-8 g/dL (or <10 in ischaemic heart disease)
FFPAll clotting factors, fibrinogen, albumin1 year (frozen)FrozenINR >1.5-2, coagulopathy, reversal of warfarin, TTP
CryoprecipitateFibrinogen, Factor VIII, vWF, Factor XIII, fibronectin1 year (frozen)FrozenFibrinogen <1.5 g/L, haemophilia A, vWD, DIC
PlateletsPlatelets in plasma5 days20-24°C with agitationCount <50 × 10⁹/L for surgery; <10 × 10⁹/L prophylactic
Fresh Whole BloodAll components intact<24 h (optimal)Not cooledMassive haemorrhage; military setting
Platelet storage warning: Stored at room temperature (20-24°C) with agitation. Shelf life 5 days. Bacterial contamination is the third leading cause of transfusion-related death - rate 1 per 2,500 units. Risk of sepsis 5x higher with platelets stored 5 days vs 4 days.

TOPIC 2: Transfusion Triggers and Decision-Making

❓ Likely OSCE Questions

  • "When do you transfuse? What is your haemoglobin trigger?"
  • "How do you assess need for further transfusion intraoperatively?"
  • "How do you measure intraoperative blood loss?"

Key Facts

Haemoglobin Trigger:
  • General: Hb 7 g/dL (restrictive threshold - well supported by evidence)
  • Ischaemic heart disease / elderly / TBI: Hb 8-10 g/dL
  • Asymptomatic, haemodynamically stable: can tolerate lower
Assessment before each subsequent transfusion:
  1. Trend in vital signs
  2. Measured and anticipated blood loss
  3. Volume of IV fluids given
  4. Current Hb/Haematocrit
  5. Surgical concerns (ongoing bleeding, procedure type)
Blood loss measurement:
  • Visual + gravimetric (weight of dry vs. blood-soaked gauze)
  • Anesthesiologists consistently overestimate blood loss by up to 40%
  • No gold standard method exists
  • Continuous non-invasive Hb monitoring available (Masimo SpHb - pulse co-oximetry)

TOPIC 3: Massive Transfusion Protocol (MTP)

❓ Likely OSCE Questions

  • "What is massive transfusion? Define it."
  • "Describe your MTP. What ratios do you use?"
  • "What is the lethal triad in trauma? How do you prevent it?"
  • "What is damage control resuscitation (DCR)?"
  • "What is the role of tranexamic acid in trauma?"

Key Facts

Definition of Massive Transfusion:
  • 10 units PRBCs in 24 hours, OR
  • 4 units in 1 hour, OR replacement of entire blood volume
Lethal Triad (Bloody Vicious Cycle):
  • Hypothermia + Acidosis + Coagulopathy
  • Each perpetuates the others; must be broken simultaneously
MTP Activation (emergency):
  • Some hospitals: 4 units O-negative uncrossmatched PRBCs + 4 units thawed AB plasma + 1 unit platelets available in ~5 minutes
Blood Product Ratios:
RatioEvidence
1:1:1 (plasma:platelets:RBCs)PROPPR trial - faster haemostasis, fewer deaths from exsanguination at 24 h
1:1:2Similar 24-h and 30-day mortality in PROPPR, but slower haemostasis
Current practice1:1:1 most commonly adopted
Key trial - PROPPR (Holcomb et al.): 1:1:1 vs 1:1:2 - no difference in mortality at 24h or 30 days, BUT 1:1:1 achieved haemostasis more rapidly and had fewer deaths by exsanguination at 24 hours.
Two paradigms of haemostatic resuscitation:
  1. DCR model - empiric ratios (approximating whole blood); used in Phase 1 (uncontrolled haemorrhage)
  2. Goal-directed haemostatic resuscitation - point-of-care viscoelastic monitoring (TEG/ROTEM) + targeted haemostatic concentrates; used in Phase 2 (controlled haemorrhage)
Calcium in MTP:
  • Hypocalcaemia is common and associated with death in massive haemorrhage
  • Citrate in stored blood chelates calcium; give calcium chloride or gluconate empirically
  • May precede blood product administration - supplement early
Other agents in coagulopathy:
  • Tranexamic acid (TXA): antifibrinolytic; shown to reduce mortality in trauma if given within 3 hours of injury (CRASH-2 trial). Also used in elective surgery (joint arthroplasty) to reduce blood loss.
  • Fibrinogen concentrate / Cryoprecipitate: when fibrinogen <1.5 g/L; most US centres use cryo due to cost
  • Prothrombin Complex Concentrate (PCC): contains factors II, VII, IX, X; for oral anticoagulant reversal and traumatic intracranial haemorrhage
  • rFVIIa: licensed for haemophilia with inhibitors; use in trauma not routinely recommended (thromboembolism risk, no mortality benefit in large RCT)

TOPIC 4: Complications of Blood Transfusion

❓ Likely OSCE Questions

  • "A patient develops fever and rigors during transfusion - what do you do?"
  • "What is TRALI? How does it differ from TACO?"
  • "What is an acute haemolytic transfusion reaction under GA? How do you recognise and manage it?"
  • "What are the infective risks of blood transfusion?"
  • "What is TRIM?"

Key Facts

Acute Haemolytic Transfusion Reaction (ABO Incompatibility)
  • Most common cause: human error (wrong blood to wrong patient) - >half the errors occur AFTER blood leaves the blood bank
  • Incidence: 1:1,200 - 1:190,000
FeatureConscious patientUnder GA
SymptomsFever, chills, chest/flank pain, nauseaMasked by anaesthesia
First signFever/rigorsHaemoglobinuria (presenting sign)
Other signs-Hypotension, bleeding diathesis
  • Free Hb appears in plasma when capacity of haptoglobin exceeded (haptoglobin binds ~100 mg Hb/100 mL plasma)
  • Haemoglobinuria occurs when plasma Hb >150 mg/dL
Management of suspected haemolytic reaction:
  1. Stop the transfusion immediately
  2. Maintain IV access - give IV fluids
  3. Check identity labels (patient vs. blood bag)
  4. Send: urine for haemoglobin, blood for direct antiglobulin test (DAT/Coombs), serum haptoglobin, plasma Hb, bilirubin
  5. Maintain urine output (fluids ± frusemide/mannitol)
  6. Treat hypotension, coagulopathy/DIC
  7. Notify blood bank
Leading causes of transfusion-related death (FDA data):
  1. TRALI
  2. TACO
  3. Bacterial contamination (from platelets)
TRALI vs TACO:
FeatureTRALITACO
MechanismImmune-mediated (donor antibodies vs. recipient WBCs)Volume overload
TimingDuring or within 6 h of transfusionDuring or within 6 h
CXRBilateral infiltratesCardiomegaly, pulmonary oedema
JVP/CVPNormal or lowElevated
BNPLow/normalElevated
TreatmentSupportive, O2, ICU, may need intubationDiuresis, O2
Mortality~5-10%Lower
Febrile Non-Haemolytic Reaction (FNHTR):
  • Fever ± chills, cough after transfusion
  • Caused by pyrogenic cytokines from donor leukocytes
  • Leukoreduction has reduced incidence
  • Rule out haemolytic reaction with DAT first
  • Treat with paracetamol
Allergic Reactions:
  • Minor (urticaria) - slow transfusion + antihistamine; do not need to stop
  • Anaphylactic - occurs in IgA-deficient patients receiving IgA-containing products (anti-IgA antibodies)
  • After only a few mL of blood; treat with epinephrine
  • Future transfusions: use washed RBCs (IgA removed)
Transfusion-Associated GVHD:
  • Donor lymphocytes engraft and attack recipient tissues
  • Risk: immunocompromised patients, directed donations from first/second-degree relatives (shared HLA)
  • Features: rash, leucopenia, thrombocytopenia → sepsis → death
  • Prevention: irradiation of blood products
Transfusion-Related Immunomodulation (TRIM):
  • Allogeneic blood has nonspecific immunosuppressive effect on recipient
  • May relate to cancer recurrence, postoperative infections, viral activation
  • Mechanism unclear; universal leukoreduction may reduce this
Infective risks (screened blood, US data):
VirusCurrent risk per unit
HIV~1:1.5 million
HCV~1:1.2 million
HBV~1:280,000
HTLV~1:641,000
West Nile virusVery low (NAT tested)
Screening uses Nucleic Acid Technology (NAT) - reduces "window period" for HIV, HCV, HBV, West Nile, Zika.

TOPIC 5: Autologous Blood & Cell Salvage

❓ Likely OSCE Questions

  • "What are the techniques of autologous blood conservation?"
  • "When is cell salvage indicated? What are its contraindications?"
  • "What are the complications of intraoperative cell salvage?"

Key Facts

Autologous blood strategies:
  1. Preoperative autologous donation (PAD) - patient donates own blood before elective surgery
  2. Acute normovolaemic haemodilution (ANH) - blood drawn at induction, replaced with crystalloid/colloid, reinfused at end
  3. Intraoperative cell salvage (ICS) - blood suctioned from field, washed, reinfused
  4. Postoperative cell salvage - blood from drains collected and reinfused (must reinfuse within 6 hours; upper limit ~1400 mL unprocessed)
Indications for ICS: Major orthopaedic, cardiac, vascular, hepatic surgery; high-risk caesarean section
Contraindications to ICS:
  • Active infection/sepsis at operative site
  • Malignancy (relative - use leukodepletion filter)
  • Bowel contamination of field
  • Use of topical haemostatics not approved for re-infusion
Complications of ICS (Box 45.5, Miller's):
  • Hypervolaemia, bacterial contamination, hypotension
  • Non-immune and immune haemolysis
  • Febrile non-haemolytic reactions, allergic reactions
  • DIC, coagulopathy
  • Air embolus
  • Reactions from reinfused anticoagulants (heparin) or other contaminants

TOPIC 6: O-Negative Universal Donor Blood

❓ Likely OSCE Questions

  • "When and why do you use O-negative blood? What are the risks?"
  • "Can you switch back to type-specific blood after emergency O-negative transfusion?"

Key Facts

  • Type O blood lacks A and B antigens - cannot be haemolysed by recipient anti-A or anti-B
  • Available in emergency in ~5 minutes from blood bank cache
  • Prefer O-negative PRBCs over O-negative whole blood - less plasma, almost free of haemolytic anti-A/anti-B antibodies
  • If whole blood must be used: blood bank must confirm it is free of haemolytic antibodies
Critical rule: If >2 units of O-negative uncrossmatched whole blood given, cannot switch to type-specific blood until blood bank confirms anti-A and anti-B antibody titres have fallen to safe levels. Switching prematurely causes major intravascular haemolysis of donor RBCs.
  • Risk of detectable haemolysis: only 0.1% in large series (10,916 uncrossmatched units)

TOPIC 7: Fresh Whole Blood

❓ Likely OSCE Questions

  • "What is fresh whole blood? What are its advantages in massive haemorrhage?"

Key Facts

  • "Fresh" = stored <24-48 hours at 2-6°C (definitions vary)
  • Retains coagulation factors, platelets, and RBC function better than stored components
  • Whole blood stored >24 hours at 4°C has less haemostatic effect than blood stored <6 hours (decreased platelet aggregability)
  • Extensively used by US military in Iraq/Afghanistan - shown effective in treating massive haemorrhage
  • Where available, effectively approximates 1:1:1 component therapy as a single product

TOPIC 8: Coagulopathy of Trauma (Acute Traumatic Coagulopathy - ATC)

❓ Likely OSCE Questions

  • "What is acute traumatic coagulopathy? How does it differ from dilutional coagulopathy?"
  • "What is the role of viscoelastic testing (TEG/ROTEM) in managing coagulopathy?"

Key Facts

  • ATC is an early, endogenous coagulopathy that occurs with shock + trauma - separate from the later dilutional coagulopathy from fluids
  • Caused by: tissue injury + shock → activated protein C → hyperfibrinolysis + anticoagulation
  • Worsened by: hypothermia + acidosis (both impair enzyme activity of clotting cascade)
TEG/ROTEM-guided resuscitation (Phase 2 - controlled haemorrhage):
  • Allows targeted replacement rather than empiric ratios
  • Identifies: clot initiation (PT/APTT), clot strength (fibrinogen, platelets), fibrinolysis
  • Guides: FFP, cryoprecipitate, platelets, TXA, PCC based on specific deficits

HIGH-YIELD OSCE SUMMARY TABLE

TopicKey Number/Fact
PRBC haematocrit57-60%
PRBC plasma K⁺20.5 mmol/L
Transfusion trigger (general)Hb 7 g/dL
Transfusion trigger (IHD/elderly)Hb 8-10 g/dL
MTP ratio1:1:1 (plasma:platelets:RBCs)
Max tourniquet duration3 hours
Emergency O-neg blood availability~5 min
Platelet storage20-24°C, agitation, 5 days
Platelet bacterial contamination rate~1:2,500 units
First sign of haemolytic reaction under GAHaemoglobinuria
Most common cause of ABO incompatibility deathHuman error (wrong patient)
IgA-deficient anaphylaxis - useWashed RBCs
GVHD preventionIrradiation of blood products
TXA: must give within3 hours of injury
PROPPR trial: 1:1:1 advantageFaster haemostasis, fewer 24-h exsanguination deaths
Cannot co-administer with PRBCsLactated Ringer's (contains Ca²⁺)
Postoperative cell salvage time limitReinfuse within 6 hours
All sources: Miller's Anesthesia, 2-Volume Set, 10th Edition (2023)

Osce questions on electrolytes

Searching sources...
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Excellent - that gave me a huge amount of content. Let me read the calcium, magnesium, and phosphate sections which were in the same block.
Reading File
Reading File
I now have comprehensive content covering all electrolytes and related physiology from Miller's Anesthesia. Let me compile the full structured OSCE notes.

Electrolytes - MD Anaesthesia OSCE: Structured Notes with Likely Questions

Source: Miller's Anesthesia, 2-Volume Set, 10th Edition

TOPIC 1: SODIUM

❓ Likely OSCE Questions

  • "What is the normal range of serum sodium? What controls it?"
  • "Classify hyponatraemia. How do you approach it?"
  • "What are the dangers of rapid correction of hyponatraemia?"
  • "What is SIADH? How does it differ from other causes of hyponatraemia?"
  • "When do you give hypertonic saline and how?"

Normal Physiology

  • Normal serum Na⁺: 138-142 mEq/L
  • Na⁺ is the dominant ECF cation - the prime determinant of ECF volume
  • Total body Na⁺: ~4000 mmol; only 10% intracellular (ICF:ECF ratio 1:15)
  • Controls serum Na⁺:
    1. Hypothalamic osmoreceptors → ADH release → water retention
    2. Atrial volume sensing → ANP release → natriuresis
    3. Juxtaglomerular apparatus → RAAS activation → Na⁺ retention
  • 99.5% of filtered Na⁺ is reabsorbed (mainly at PCT)
  • Daily requirement: adults 1-1.5 mEq/kg/day

Hyponatraemia (Na⁺ < 135 mEq/L)

Classification by tonicity:
TypeSerum osmolalityCauses
Hypo-osmolar (true)LowSIADH, heart failure, cirrhosis, renal failure, hypothyroidism, Addison's
Iso-osmolar (pseudohyponatraemia)NormalHyperlipidaemia, hyperproteinaemia (lab artefact)
HyperosmolarHighHyperglycaemia, mannitol, contrast media (water moves out of cells)
Hypo-osmolar hyponatraemia - by volume status:
Volume statusECFCauseUrine Na⁺
HypovolaemicDiuretics, GI losses, adrenal insufficiency<20 mEq/L (renal conservation) or >20 (diuretics)
EuvolaemicNormalSIADH, hypothyroidism, psychogenic polydipsia>20 mEq/L
HypervolaemicHeart failure, cirrhosis, nephrotic syndrome<20 mEq/L
SIADH criteria (euvolaemic hypo-osmolar hyponatraemia):
  • Plasma osmolality <280 mOsm/kg
  • Urine osmolality >100 mOsm/kg (inappropriately concentrated)
  • Urine Na⁺ >20 mEq/L (Na⁺ wasting)
  • Clinically euvolaemic
  • Normal renal, adrenal, and thyroid function

Clinical Features of Hyponatraemia

Na⁺ (mEq/L)Symptoms
130-135Usually asymptomatic
125-130Nausea, malaise
<125Headache, lethargy, confusion
<120Seizures, respiratory arrest, cerebral oedema, death
Anaesthetic concern: Hyponatraemia → cerebral oedema + elevated ICP + increased sensitivity to anaesthetic agents; increased risk of seizures perioperatively.

Correction of Hyponatraemia

⚠️ The most dangerous complication: Osmotic Demyelination Syndrome (ODS) / Central Pontine Myelinolysis (CPM) - caused by TOO RAPID correction.
Rule: Correct no faster than 8-10 mEq/L per 24 hours (max 12 mEq/L/24h). In severe symptomatic cases, an initial rapid correction of 1-2 mEq/L/hour is permitted for the first 2-3 hours only (to stop seizures), then slow down.
Treatment by type:
  • Hypovolaemic: 0.9% saline to restore volume (Na⁺ will self-correct as ADH drops)
  • SIADH: fluid restriction ± loop diuretics; vasopressin receptor antagonists (vaptans) for refractory cases
  • Severe symptomatic (seizures): 3% hypertonic saline - give via central vein (NaCl >7.5% causes endothelial damage)
Hypertonic saline indications:
  • Hypo-osmolar hyponatraemia correction
  • ↑ Intracranial pressure (reduces cerebral oedema; may be superior to mannitol)
  • NOT for TBI without confirmed ↑ICP (not shown beneficial in trials)

Hypernatraemia (Na⁺ > 145 mEq/L)

Causes: Water deficit > Na⁺ excess
  • Inadequate water intake (elderly, intubated patients, impaired thirst)
  • Excess water loss: diabetes insipidus (DI), osmotic diuresis, fever, burns
  • Iatrogenic: NaHCO₃ therapy, hypertonic saline, enteral feeds
Clinical features: Thirst, confusion, restlessness, seizures, coma; brain shrinkage (risk of subdural haemorrhage)
Correction: Replace free water deficit slowly (max 10-12 mEq/L/24h) - rapid correction → cerebral oedema
  • Formula: Free water deficit = 0.6 × weight (kg) × [(Na/140) - 1]
  • Use 5% dextrose or 0.45% saline

TOPIC 2: POTASSIUM

❓ Likely OSCE Questions

  • "What are the ECG changes in hyperkalaemia? How do you treat it urgently?"
  • "Why is hypokalaemia dangerous in anaesthesia?"
  • "What causes a shift of K⁺ into/out of cells? How does this affect serum K⁺?"
  • "What is your threshold for operating on a patient with hypokalaemia/hyperkalaemia?"

Normal Physiology

  • Normal serum K⁺: 3.5-5.0 mEq/L
  • K⁺ is the dominant ICF cation - 98% intracellular (muscle, liver, RBCs)
  • Total body K⁺: ~4000 mmol; only ~70 mEq in ECF
  • Vital for resting membrane potential of all excitable tissues
  • Na⁺/K⁺-ATPase: exports 3 Na⁺ for 2 K⁺ inward - maintains gradient
Factors causing K⁺ shift INTO cells (↓ serum K⁺):
  • Insulin (stimulates Na⁺/K⁺-ATPase)
  • β₂-adrenergic agonists (salbutamol, adrenaline - stimulate Na⁺/K⁺-ATPase) → clinically useful for treatment
  • Alkalosis (H⁺ leaves cells, K⁺ enters)
  • Glucose (stimulates insulin)
Factors causing K⁺ shift OUT of cells (↑ serum K⁺):
  • Acidosis (especially mineral acids - inorganic H⁺ cannot enter cells freely, so H⁺/K⁺ exchange)
  • Suxamethonium - depolarises all muscle → K⁺ efflux (~0.5 mEq/L rise normal; 5-10 mEq/L rise in burns, paraplegia, denervation)
  • Digoxin (inhibits Na⁺/K⁺-ATPase)
  • Cell lysis (haemolysis, rhabdomyolysis, tumour lysis)
  • Hyperosmolar states (osmotic drag)
  • Beta-blockade

Hypokalaemia (K⁺ < 3.5 mEq/L)

Causes:
  • GI losses: vomiting (alkalosis → kaliuresis), diarrhoea, bowel prep, NG suction, fistulas
  • Renal losses: diuretics (thiazides, loop), hyperaldosteronism, Cushing's, RTA, Mg²⁺ deficiency
  • Cellular shift: insulin therapy, β₂-agonists, alkalosis, refeeding syndrome
  • Inadequate intake (rare in isolation)
Note: Vomiting causes metabolic alkalosis + hypokalaemia (both from H⁺ + Cl⁻ loss in gastric juice, and from secondary aldosterone activation → renal K⁺ wasting)
Clinical features:
  • Muscle weakness, cramps, fatigue, ileus, polyuria (nephrogenic DI)
  • ECG changes: T-wave flattening/inversion, prominent U waves, ST depression, widened QRS; at severe levels: VT/VF
Anaesthetic implications of hypokalaemia:
  • Enhanced sensitivity to non-depolarising muscle relaxants
  • Risk of arrhythmias (especially in digitalis patients)
  • Impaired respiratory muscle function → delayed extubation
  • Paradoxical aciduria in metabolic alkalosis
  • Operating threshold: Elective surgery generally safe if K⁺ ≥ 3.0 mEq/L; aim ≥ 3.5 mEq/L in patients on digoxin or with cardiac disease
Treatment:
  • Oral KCl preferred for mild-moderate
  • IV KCl for severe or unable to take orally: max 20-40 mEq/hour peripherally (peripheral vein limit: 40 mEq/L concentration; central line for higher concentrations/rates)
  • Always correct Mg²⁺ first - hypokalaemia refractory to K⁺ replacement without correcting hypomagnesaemia
  • Rule of thumb: 1 mEq/L fall in serum K⁺ ≈ 200-400 mEq total body deficit

Hyperkalaemia (K⁺ > 5.5 mEq/L)

Causes:
  • Renal failure (most common)
  • ACE inhibitors, ARBs, K⁺-sparing diuretics, NSAIDs
  • Suxamethonium (burn, denervation, crush injuries, prolonged immobility)
  • Acidosis, rhabdomyolysis, haemolysis, massive blood transfusion
  • Adrenal insufficiency, hypoaldosteronism
  • Pseudohyperkalaemia (haemolysed sample, thrombocytosis)
ECG changes (in order of progression):
  1. Tall peaked ("tented") T waves - first change (K⁺ ~5.5-6.5)
  2. Prolonged PR interval (K⁺ ~6.5-7)
  3. Widened QRS (K⁺ ~7-8)
  4. Sine wave pattern (K⁺ ~8-9)
  5. VF / asystole (K⁺ > 9-10)
Emergency Treatment (K⁺ > 6.5 or ECG changes):
StepDrugDoseMechanismOnsetDuration
1. Membrane stabilisationCalcium gluconate 10%10 mL IV over 2-3 minAntagonises cardiac membrane effect1-3 min30-60 min
2. Shift K⁺ into cellsInsulin + Dextrose10 units actrapid + 50 mL 50% dextroseStimulates Na⁺/K⁺-ATPase15-30 min4-6 h
3. Shift K⁺ into cellsSalbutamol (nebulised or IV)10-20 mg nebulisedβ₂-agonist → Na⁺/K⁺-ATPase15-30 min4-6 h
4. Shift K⁺ into cellsNaHCO₃ (if acidotic)50-100 mEq IVAlkalosis drives K⁺ intracellularly15-30 minVariable
5. Remove K⁺ from bodyFrusemide (if urine output)40-80 mg IVRenal K⁺ excretion30-60 min-
5. Remove K⁺ from bodyResonium/PatiromerOral/PRIon exchange resinHours-
6. DefinitiveDialysis/Haemofiltration-Removes K⁺ directlyImmediate (on circuit)-
⚠️ Suxamethonium contraindicated in: burns >24-48h, spinal cord injury, prolonged immobility, denervation injuries, severe trauma - risk of hyperkalaemic cardiac arrest.

TOPIC 3: CALCIUM

❓ Likely OSCE Questions

  • "What forms does calcium exist in plasma? Which is physiologically active?"
  • "What are the signs of hypocalcaemia? Chvostek's and Trousseau's signs?"
  • "When does hypocalcaemia occur perioperatively?"
  • "How does pH affect ionised calcium?"

Normal Physiology

  • Normal total serum Ca²⁺: 2.2-2.6 mmol/L (8.5-10.5 mg/dL)
  • Normal ionised Ca²⁺: 1.1-1.3 mmol/L - the physiologically active fraction
  • Distribution:
    • 40-50% bound to albumin (inactive)
    • 5-10% complexed with anions (citrate, phosphate, bicarbonate) (inactive)
    • 45-50% ionised (active)
Correction for albumin: For every 10 g/L fall in albumin below 40 g/L, add 0.2 mmol/L to total Ca²⁺
pH effect on ionised Ca²⁺:
  • Alkalosis → more Ca²⁺ binds albumin → ↓ ionised Ca²⁺ → symptoms of hypocalcaemia (e.g., hyperventilation tetany)
  • Acidosis → less binding → ↑ ionised Ca²⁺
Hormonal control:
  • PTH ↑: ↑ bone resorption, ↑ renal Ca²⁺ reabsorption, ↑ 1,25-OH-Vit D synthesis → ↑ Ca²⁺
  • Calcitonin ↓: ↓ bone resorption → ↓ Ca²⁺
  • Vitamin D (1,25-OH): ↑ intestinal Ca²⁺ absorption
Role of Ca²⁺ in anaesthesia: Cardiac contractility, neuromuscular transmission, coagulation (factor activation), vasomotor tone.

Hypocalcaemia (ionised Ca²⁺ < 1.1 mmol/L)

Perioperative causes:
  • Massive blood transfusion (citrate in stored blood chelates Ca²⁺) - important! Give CaCl₂/Ca gluconate in MTP
  • Post-thyroid/parathyroid surgery (hypoparathyroidism)
  • Acute pancreatitis
  • Alkalosis (hyperventilation)
  • Hypomagnesaemia (impairs PTH secretion and action)
  • Rhabdomyolysis, tumour lysis, renal failure
  • Vitamin D deficiency
Clinical features:
SystemFeature
NeuromuscularParaesthesias (perioral, fingertips), muscle cramps, tetany, laryngospasm
SignsChvostek's sign (facial muscle twitch on tapping CN VII at parotid), Trousseau's sign (carpal spasm with BP cuff inflated > systolic for 3 min)
CardiacProlonged QT interval, bradycardia, heart block, hypotension, impaired contractility
CNSConfusion, seizures
ECG: Prolonged QT interval (increased risk of torsades de pointes)
Treatment:
  • Symptomatic/acute: 10% Calcium gluconate 10-20 mL IV (preferred; 10% CaCl₂ if cardiac arrest - more elemental Ca²⁺ per mL, but more irritant to veins)
  • Calcium gluconate contains 2.25 mmol elemental Ca²⁺ per 10 mL; CaCl₂ contains 6.8 mmol per 10 mL
  • Chronic: oral calcium + Vitamin D supplements
⚠️ Do NOT give calcium and bicarbonate in the same line - will precipitate as CaCO₃

Hypercalcaemia (total Ca²⁺ > 2.6 mmol/L; severe >3.5 mmol/L)

Causes (80-90% are hyperparathyroidism or malignancy):
  • Primary hyperparathyroidism (outpatient, usually mild)
  • Malignancy (PTHrP secretion, bone mets, haematological malignancy)
  • Vitamin D toxicity, sarcoidosis, thyrotoxicosis, immobility (Paget's), thiazides, lithium
Mnemonic: "Bones, Stones, Groans, Psychic Moans"
  • Bones: pain, pathological fractures
  • Stones: renal calculi, nephrocalcinosis
  • Groans: nausea, vomiting, constipation, peptic ulceration, pancreatitis
  • Psychic moans: depression, confusion, psychosis, coma
ECG: Shortened QT interval
Anaesthetic implications:
  • Reduced neuromuscular blockade response (increased resistance to NDNMBs? - actually hypercalcaemia ENHANCES ACh release and may antagonise NDNMBs)
  • Digitalis toxicity potentiated
  • Hypovolaemia (polyuria)
Treatment of acute hypercalcaemia:
  1. IV saline hydration (2-4 L/24h) - first step
  2. Frusemide (after rehydration, promotes calciuresis)
  3. IV bisphosphonates (zoledronate, pamidronate) - 24-48h to effect
  4. Calcitonin (rapid but short-lived)
  5. Steroids (sarcoidosis, vitamin D toxicity, haematological malignancy)
  6. Dialysis (severe/refractory)

TOPIC 4: MAGNESIUM

❓ Likely OSCE Questions

  • "What is the role of magnesium in anaesthesia?"
  • "What are the signs of magnesium toxicity during infusion?"
  • "When do you use magnesium perioperatively?"
  • "Why must you correct magnesium before replacing potassium?"

Normal Physiology

  • Normal serum Mg²⁺: 0.7-1.0 mmol/L (1.5-2.5 mEq/L)
  • 99% intracellular; only 1% extracellular
  • 30% of serum Mg²⁺ bound to albumin; 70% ionised or complexed
  • Cofactor for >300 enzyme reactions including Na⁺/K⁺-ATPase
  • Regulates K⁺ handling: Mg²⁺ deficiency → renal K⁺ wasting → refractory hypokalaemia

Hypomagnesaemia (Mg²⁺ < 0.7 mmol/L)

Causes:
  • Chronic alcoholism (most common in surgical patients)
  • Poor intake, malabsorption, diarrhoea
  • Loop diuretics, aminoglycosides, cisplatin, PPIs
  • DKA treatment (insulin-driven shift)
  • Refeeding syndrome
Clinical features:
  • Neuromuscular: tremor, muscle weakness, tetany, seizures (similar to hypocalcaemia)
  • Cardiac: prolonged QT, broad T-waves, torsades de pointes, VF
  • Hypokalaemia and hypocalcaemia refractory to replacement (Mg²⁺ needed for PTH secretion and renal K⁺/Ca²⁺ conservation)
Anaesthetic uses of Mg²⁺:
  • Tocolysis (premature labour) - uterine relaxation
  • Pre-eclampsia/eclampsia - seizure prophylaxis and treatment (loading dose 4-6 g IV over 15-20 min, then 1-2 g/h infusion)
  • Analgesia - adjunct in multimodal regimens (NMDA receptor antagonist)
  • Bronchospasm - refractory bronchospasm/status asthmaticus
  • Arrhythmias - Torsades de pointes (1-2 g IV bolus), digoxin toxicity arrhythmias
  • Potentiates NDNMBs - reduces the dose required; prolongs block duration
  • Anti-hypertensive (prevents autonomic instability, obtunds laryngoscopy response)

Magnesium Toxicity

Critical for OSCE: know the levels and signs
Mg²⁺ level (mmol/L)Sign
1.5-2.5Normal therapeutic range
2.5-3.5Nausea, flushing, sedation, double vision
3.5-5.0Loss of deep tendon reflexes (first clinical sign of toxicity - check patellar reflex)
5.0-6.5Somnolence, slurred speech
6.5-7.5Respiratory muscle paralysis (most dangerous)
>10Cardiac arrest
Monitoring during Mg²⁺ infusion (pre-eclampsia):
  • Patellar (knee-jerk) reflex - check before each dose; loss = STOP infusion
  • Urine output >25-30 mL/h (Mg²⁺ renally excreted)
  • Respiratory rate >12/min
  • Serum Mg²⁺ levels
Antidote: Calcium gluconate 10% - 10 mL IV (antagonises Mg²⁺ effects at membrane)

TOPIC 5: PHOSPHATE

❓ Likely OSCE Questions

  • "What are the consequences of hypophosphataemia?"
  • "When does refeeding syndrome occur and why?"

Normal Physiology

  • Normal serum phosphate: 0.8-1.5 mmol/L
  • 85% in bone as hydroxyapatite; intracellular phosphate essential for ATP synthesis
  • Inversely related to calcium (PTH ↑ phosphaturia)

Hypophosphataemia (PO₄ < 0.8 mmol/L)

Causes:
  • Refeeding syndrome (most important perioperatively): glucose infusion → insulin → massive cellular uptake of phosphate, K⁺, Mg²⁺ → plasma levels crash
  • Malnutrition, alcohol, malabsorption
  • Antacids (bind phosphate in gut)
  • DKA recovery (insulin drives intracellular shift)
  • Hyperparathyroidism
Refeeding syndrome: Occurs in malnourished patients given carbohydrate after a period of starvation (TPN, enteral feeds). Prevent by starting feeds slowly, supplementing K⁺, Mg²⁺, phosphate, and thiamine.
Consequences of severe hypophosphataemia:
  • Impaired diaphragm/respiratory muscle function → failure to wean from ventilator
  • Haemolytic anaemia (RBC membrane dysfunction)
  • Impaired leukocyte function → infection
  • Cardiomyopathy
  • Encephalopathy, seizures

HIGH-YIELD OSCE SUMMARY TABLE

ElectrolyteLow - key signLow - key treatmentHigh - key signHigh - key treatment
Na⁺Seizures (Na⁺ <120)3% NaCl (slow, max 8-10 mEq/24h)Confusion, hyperreflexiaFree water replacement (slow)
K⁺U waves on ECGKCl IV; fix Mg²⁺ firstPeaked T waves → sine waveCaGluconate → insulin/dextrose → salbutamol → dialysis
Ca²⁺Prolonged QT, Trousseau's, Chvostek's, laryngospasmCaGluconate 10 mL IVShort QT, "bones/stones/groans/moans"IV saline → frusemide → bisphosphonates
Mg²⁺Torsades, refractory ↓K⁺/↓Ca²⁺MgSO₄ IVLoss of patellar reflex → resp arrestCaGluconate 10 mL IV
PO₄Failure to wean ventilatorPhosphate replacementHypocalcaemia (binds Ca²⁺)Saline, dialysis

KEY PERIOPERATIVE RELATIONSHIPS (OSCE GOLD)

ScenarioElectrolyte disturbanceMechanism
Massive transfusion↓ Ca²⁺, ↓ Mg²⁺, ↓ K⁺ (then ↑K⁺)Citrate chelates; stored blood K⁺ release
Vomiting (NGT, bowel obstruction)↓ K⁺, ↓ Cl⁻, ↓ H⁺ (metabolic alkalosis)Gastric HCl loss → secondary hyperaldosteronism → renal K⁺ wasting
Diarrhoea↓ K⁺, ↓ HCO₃⁻ (metabolic acidosis)Large bowel secretions high in K⁺ and HCO₃⁻
Refeeding↓ PO₄, ↓ K⁺, ↓ Mg²⁺Insulin-driven cellular uptake
Suxamethonium (burns/denervation)↑ K⁺Upregulation of extrajunctional AChRs → massive depolarisation
Hyperventilation↓ ionised Ca²⁺ (not total)Alkalosis → Ca²⁺ binds albumin
Acid-base disturbancesK⁺ shifts inversely with pHMineral acid: K⁺ rises 0.4-0.6 mEq/L per 0.1 pH unit fall
Pre-eclampsia treatment↑ Mg²⁺ (therapeutic)MgSO₄ infusion; monitor patellar reflex
Bowel prep↓ K⁺, dehydrationReplace with crystalloid + K⁺ supplementation
Source: Miller's Anesthesia, 2-Volume Set, 10th Edition (2023)
This is a shared conversation. Sign in to Orris to start your own chat.